Birchview Capital, LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$766,255
+46.9%
571,832
+96.3%
0.65%
+66.8%
Q2 2023$521,484
+45926.8%
291,3320.0%0.39%
-55.9%
Q1 2023$1,133
+14.3%
291,3320.0%0.89%
+26.7%
Q4 2022$991
-99.9%
291,332
+8.2%
0.70%
-32.4%
Q3 2022$1,471,000
+21.1%
269,3320.0%1.04%
+17.2%
Q2 2022$1,215,000
-38.8%
269,3320.0%0.88%
-38.1%
Q1 2022$1,985,000
+25.5%
269,332
+9.5%
1.43%
+40.1%
Q4 2021$1,582,000
+10.5%
246,0000.0%1.02%
+4.7%
Q3 2021$1,432,000
-39.7%
246,000
+7.0%
0.97%
-31.4%
Q2 2021$2,374,000
-1.9%
230,0000.0%1.42%
-1.2%
Q1 2021$2,420,000
-16.8%
230,000
+22.3%
1.44%
-14.3%
Q4 2020$2,910,000
-40.7%
188,000
-44.0%
1.68%
+2.3%
Q3 2020$4,906,000
+54.2%
336,000
+100.0%
1.64%
-14.8%
Q2 2020$3,182,000
+11.9%
168,000
+13.5%
1.92%
-23.8%
Q1 2020$2,843,000
+85.3%
148,000
+85.0%
2.52%
+126.2%
Q4 2019$1,534,000
+127.9%
80,000
+14.3%
1.12%
+148.9%
Q3 2019$673,000
+60.6%
70,0000.0%0.45%
+75.7%
Q2 2019$419,000
+2.4%
70,0000.0%0.26%
-0.4%
Q1 2019$409,000
-37.7%
70,0000.0%0.26%
-58.8%
Q4 2018$656,000
-23.0%
70,000
+40.0%
0.62%
+12.9%
Q3 2018$852,000
+0.2%
50,0000.0%0.55%
-4.8%
Q2 2018$850,00050,0000.58%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders